Inflammatory colitis and chronic granulomatous disease, a steroid-dependent case report;Colite inflammatoire et granulomatose septique, à propos d'un cas de cortico-dépendance

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 4, 2004, Pages 398-401

  Zanditenas, David ^a   Hagège, Hervé ^a   Rosa, Isabelle ^a   Cattan, Philippe ^a   Ratel Saby, Sylvie ^a   Lons, Thierry ^a   Chousterman, Michel ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; STEROID;

ADULT; ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; ENTERITIS; FOLLOW UP; HUMAN; INFECTION; MALE; STEROID THERAPY; TOTAL COLON RESECTION; TREATMENT OUTCOME;

EID: 2542493868     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)94942-1     Document Type: Article

References (15)

1. Morel F, Boulay F, Doussière J, Vignais P. Bases moléculaires de 1a granulomatose septique. Médecine Sciences 1992;8:912-20.
2. Sloan JM, Cameron CH, Maxwell RJ, McCluskey DR, Collins JS. Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut 1996;38:619-22.
3. e ed. Paris: Flammarion 1996;719:2561-2.
4. Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001;344:881-8.
5. Dean AF, Janota I, Thrasher A, Robertson I, Mieli-Vergani G. Cerebral aspergilloma in a child with autosomal recessive chronic granulomatous disease. Arch Dis Child 1993;68:412-4.
6. Seger RA, Ezekowitz RA. Treatment of chronic granulomatous disease. Immunodeficiency 1994;5:113-30.
7. Johnson FE, Humbert JR, Kuzela DC, Todd JK, Lilly JR. Gastric outlet obstruction due to X-linked chronic granulomatous disease. Surgery 1975;78:217-23.
8. Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr 1995;126:143-5.
9. Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998;42:127-30.
10. Werlin SL, Chusid MJ, Caya J, Oechler HW. Colitis in chronic granulomatous disease. Gastroenterology 1982;82:328-31.
11. Eckert JW, Abramson SL, Starke J, Brandt ML. The surgical implications of chronic granulomatous disease. Am J Surg 1995;169:320-3.
12. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 1991;324:509-16.
13. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med 1992; 326:1666-9.
14. Van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109:129-35.
15. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.